Unit EXPERIMENTAL PHARMACOLOGY
- Course
- Chemistry and technology of drugs
- Study-unit Code
- 65982006
- Location
- PERUGIA
- Curriculum
- In all curricula
- Teacher
- Ciriana Orabona
- Teachers
-
- Ciriana Orabona
- Hours
- 114 ore - Ciriana Orabona
- CFU
- 6
- Course Regulation
- Coorte 2015
- Offered
- 2018/19
- Learning activities
- Caratterizzante
- Area
- Discipline biologiche e farmacologiche
- Academic discipline
- BIO/14
- Type of study-unit
- Obbligatorio (Required)
- Type of learning activities
- Attività formativa monodisciplinare
- Language of instruction
- Italian
- Contents
- Experimental pharmacological basis for the development of new drugs. Principles of evaluation of drug efficacy and toxicity; preclinical and clinical experimentation. Cloning and validation of a drug target.
- Reference texts
- Paoletti R., Nicosia S., Clementi F., Fumagalli G. Trattato di farmacologia e terapia - vol. Farmacologia clinica. e vol. farmacologia generale e molecolare. UTETRichard J Reece ‘Analisi dei geni e dei genomi' EDISESJeremy W. Dale e Malcolm von Schantz ‘Dai geni ai genomi' EDISES
- Educational objectives
- Knowledge of the experimental pharmacological methods.
- Prerequisites
- In order to be able to understand and apply the experimental procedures described within the Course, you must have successfully passed 'Farmacologia, Farmacognosia e Tossicologia Generale' exam. The same examination is a prerequisite for attending the practical course.Moreover, a good knowledge of molecular biology and a good training in math should be useful for following with profit this course.
- Teaching methods
- Theoretical lessons and practical training
- Other information
- Mandatory attendance
- Learning verification modality
- L'esame prevede una prova scritta, una prova orale e la presentazione di un elaborato tecnico prodotto autonomamente durante il corso pratico. La prova scritta consiste in un test a risposta multipla, costituito da 30 domande da eseguire in un'ora. L'esame orale consiste in una discussione di circa 20 minuti finalizzata ad accertare il livello di conoscenza e capacità di applicazione di tali conoscenze a problematiche di farmacologia sperimentale. L'elaborato tecnico da presentare contestualmente all'esame orale è rappresentato da un quaderno di laboratorio che lo studente deve curare durante il corso pratico, corredato con i risultati sperimentali ottenuti con relativo commento.
Per informazioni sui servizi di supporto agli studenti con disabilità e/o DSA visita la pagina http://www.unipg.it/disabilita-e-dsa - Extended program
- Theoretical lessons: Introduction to the research of innovative drug targets and molecules as lead compounds for the development of new drug.IDO1 enzyme as an example of drug target in autoimmune and cancer diseases. End-point, real-time and digital PCR as tools for the evaluation of the drug effect on gene transcription. Microarray and gene chips for the evaluation of the drug effect on the transcriptome. High throughput screening (HTS): a method for selecting ‘lead’ compounds. In vitro and ex vivo preclinical methods of drug study: cell cultures and isolated organs. Methods of study of the signal transduction for the identification of potential drug targets. In vivo preclinical study: the 3R principle; alternative methods to the animal experimentation; animals used in research and their maintenance in animal facility; the Irwin’s test; experimental models of disease. Mice genetically modified: transgenic, knock-out, knoch-in and conditional transgenic/knock-out mice. Clinical trial design: scientific and statistical hypothesis, principles of biostatistics; endpoints; bias and variability; randomization. Phases of Clinical Trials. Genetically modified organisms (OGM) for the production of oral vaccines. MicroRNAs (miRNA) as new drug targets.Virtual training: Mouse watch, virtual observational study of the in vivo drug effect. Langerdorf’s hearth: virtual experimentation on isolated organ.Practical training: Cloning, expression and validation of the enzyme IDO as a drug target. Purification and activation of murine spleen cells; RNA extraction, RT-PCR for the amplification of the drug target gene; cloning of the drug target gene in a plasmid. Transfection and expression of the drug target gene in a cell line. Validation of the drug target by analysis of the protein expression and the catalytic activity. Building of dose-response curves using the cloned drug target and evaluation of the IC50 of different molecules.